Skip to main content

Oncology news

17-08-2016 | Leukaemia | Highlight | Article
Editor's pick

PROs best with bone marrow unrelated donor transplantation

For patients undergoing unrelated donor haematopoietic cell transplantation, bone marrow should be used as the graft source instead of peripheral blood, say researchers who found that bone marrow recipients fared better with respect to certain self-reported measures.

Source:

JAMA Oncol 2016; Advance online publication

PD-1 Therapy Shows Promise For Acral, Mucosal, Select Uveal Melanoma Patients

Preliminary findings suggest potential for programmed cell death protein 1 inhibitor therapy in acral and mucosal melanoma and perhaps uveal disease

Read the full story on ESMO's oncologyPRO educational website (for registered ESMO members).

approvalsWatch: Oncology

medwireNews@ECC2015

medwireNews@ECC2015

medwireNews brings you coverage of the 2015 European Cancer Congress, held in Vienna, Austria.

Click through to read the full reports of the latest research.

Twitter Icon Follow medwireNews

Click here
image credits